CCB Capital logo

CCB Capital

Asia, Beijing, China, Beijing

Description

CCB Capital is an asset management company.

Investor Profile

CCB Capital has made 5 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (40%)
  • Series D (20%)
  • Series E (20%)
  • Series C (20%)

Country Focus

  • China (100%)

Industry Focus

  • Health Care
  • Hardware
  • Optical Communication
  • Automotive
  • Electric Vehicle
  • Industrial
  • Biopharma
  • Biotechnology
  • Electronics
  • Mobile
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CCB Capital frequently co-invest with?

FutureCap
Asia, Beijing, China, Beijing
Co-Investments: 1
CD
Asia, Beijing, China, Beijing
Co-Investments: 1
Chenhui Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Kinzon Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Co-Investments: 1
BOCOM International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 2
Shenzhen Capital Group
Asia, Hunan, China, Nanshan
Co-Investments: 2
Country Garden Venture Capital
Asia, Jilin, China, Guangdong
Co-Investments: 1
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 3
CITIC Zhengye
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by CCB Capital?

TONGYU AUTOMOTIVE

Jiading, Shanghai, China

TONGYU AUTOMOTIVE is an intelligent driving system development company.

AutomotiveElectric VehicleIndustrial
Series BDec 4, 2023
Amount Raised: $70,542,756
Chipone Technology

Beijing, Beijing, China

Chipone Technology is a chip design company engaged in the design of display chips for LED displays and LCD panels.

ElectronicsMobileProduct Design
Series EDec 15, 2021
Amount Raised: $1,020,792,763
North Ocean Photonics

Shanghai, Shanghai, China

North Ocean Photonics is a high-tech enterprise focusing on the field of micro-optics and optical integration.

HardwareOptical Communication
Series BNov 22, 2021
Beijing Gene+ Technology

Changping, Beijing, China

Beijing Gene+, also known as Beijing Gene Plus, provides gene testing services for cancer prevention

Health CareLife ScienceMedical
Series CJul 22, 2021
Amount Raised: $115,907,089
Akeso Biopharma

Zhongshan, Anhui, China

Akeso Biopharma is a biopharmaceutical company committed to the discovery, development, and commercialization of therapies.

BiopharmaBiotechnologyHealth Care
Series DNov 4, 2019
Amount Raised: $150,000,000